Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ketoconazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 48 for your search:
Start Over
VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113971, NCT01205230
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: any age
Sponsor: NCI, Other
Protocol IDs: CDR0000064708, U10CA031946, CLB-9583, CALGB-9583, NCT00002760
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, NCI-2009-00009, 3410, NCT00024167
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-81-C-189, NCI-POB-8103
Phase III MOX/AMK vs MOX/PIP for Suspected Infection in Febrile, Granulocytopenic Cancer Patients, with Amphotericin-B or Ketoconazole for Failures
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8107
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069088, E1899, SWOG-E1899, CALGB-E1899, ECOG-E1899, NCT00027859
Phase I/II Study of IL-1A/MITO with Ketoconazole for Metastatic Colorectal and Prostate Carcinomas (Summary Last Modified 08/95)
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CRB-9202, NCI-T94-0090N, T94-0090
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000393439, AECM-03099, AECM-CA163402, AECM-NMC-03-10-277C, NCT00096317
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-374, NCT00953576
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017539, ET7430VC1003, NCT01267084
Phase II Randomized Study of Ketoconazole vs DOX/Ketoconazole in Hormone-Refractory Prostate Carcinoma (Summary Last Modified 04/95)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MDA-DM-95010, NCI-T95-0012D, T95-0012
Phase II Randomized Study of Tretinoin Modulation by Ketoconazole or Disulfiram in Hormone-Refractory Prostate Cancer (Summary Last Modified 01/99)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: PCI-9437, NCI-T94-0173D, T94-0173
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: DM97-022, P30CA016672, MDA-DM-97022, NCI-T97-0023, CDR0000065783, T97-0023, NCT00003084
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 00-113, MSKCC-00113, NCI-G01-1927, NCT00014352
Phase II Pilot Study of the Effects of High-Dose Ketoconazole in the Management of Stage D Prostatic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCOG-P-4P831, NCOG-P-4P-83-1
Phase II Study of Endocrine Therapy with Ketoconazole in Patients with Metastatic Prostate Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-8586, NCI-T86-0145D, T86-0145
Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036
Phase II Study of Taxol and G-CSF in Patients with Refractory or Recurrent Ovarian Cancer (Summary Last Modified 04/93)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-191G, NCI-T90-0219N, T90-0219
Phase II Study of VP-16 plus Chemotherapy Resistance Modulators in the Treatment of VP-16-Resistant Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-OTT-9008, NCI-V91-0084
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BR01/07/05, NCT00212095
Start Over